Seres Therapeutics Q1 2017 Earnings Report

Total Revenue
$3.02M
Previous year: $2.71M
+11.3%
EPS
-$0.63
Previous year: -$0.5
+26.0%

Seres Therapeutics

Seres Therapeutics